Reports Q1 revenue $1.58B, consensus $1.54B. “First quarter results exceeded our expectations due to improved execution in Bioscience and Medtech Products, and we saw stabilization in VWR,” said Emmanuel Ligner, President and Chief Executive Officer. “Revival is already having a positive impact, and I am encouraged by the momentum and positive energy across the organization,” Ligner concluded.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- Avantor Appoints New Executive VP and Transformation Leader
- Avantor appoints Ludovic Brellier Chief Transformation Officer
- Avantor unifies Masterflex portfolio to include fluid handling
- Avantor price target lowered to $7 from $8.50 at Barclays
- Avantor adds advanced microbial, stability testing at St. Louis site